Wellington Management Group
IGMS

Wellington Management Group’s IGM Biosciences IGMS Stock Holding History

Wellington Management Group’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-101,055
Closed -$617K – 1992
2024
Q4 		$617K Buy
101,055
+2,716
+3% +$32.3K ﹤0.01% 1804
2024
Q3 		$1.63M Buy
98,339
+29,374
+43% +$322K ﹤0.01% 1597
2024
Q2 		$474K Buy
68,965
+11,775
+21% +$101K ﹤0.01% 1784
2024
Q1 		$552K Buy
+57,190
New +$663K ﹤0.01% 1797

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Wellington Management Group's IGMS Position: Q1 2025 in Review

Wellington Management Group sold out of IGM Biosciences (IGMS) in Q1 2025, closing a stake of 101,055 shares — an estimated $617K sold.

Wellington Management Group first reported a position in IGMS in Q1 2024 and held it in 4 quarters. The position peaked at $1.63M in Q3 2024. 79 funds tracked by Wall St. Rank hold IGMS as of Q1 2025.

  • Wellington Management Group reported no remaining IGM Biosciences position as of Q1 2025 after selling out during the quarter.
  • Wellington Management Group sold 101,055 IGM Biosciences shares in Q1 2025, an estimated $617K.
  • Wellington Management Group first reported a position in IGM Biosciences in Q1 2024 and held it in 4 quarters.
  • Wellington Management Group's IGM Biosciences position peaked at $1.63M in Q3 2024.
  • 79 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2025.

Based on Wellington Management Group's 13F filing for Q1 2025, filed 13 May 2025.